Obesity Shakes the Market: How GLP-1 is Reshaping US Pharma

Obesity Shakes the Market: How GLP-1 is Reshaping US Pharma

Tuesday, May 20, 2025 10:00 AM to 10:20 AM · 20 min. (America/New_York)
Main Stage Theater
Track - Market Trends in Pharma

Information

As GLP-1 therapies gain traction in combating obesity nationwide, their success is transforming the pharmaceutical landscape.

Topic
ManufacturingSupply ChainMarket Insights

Registered attendees

Ali Al-Khattawi
Ali Al-Khattawi
CEO and FounderMESOX
AD
Ashleigh Dailey
GMP Raw Materials Area SpecialistNovo Nordisk
Bassem Gayed
Bassem Gayed
Senior Director Cell Therapy Technical OperationBristol Myers Squibb